Literature DB >> 32418647

Cortisol, inflammatory biomarkers and neurotrophins in children and adolescents with attention deficit hyperactivity disorder (ADHD) in Taiwan.

Jane Pei-Chen Chang1, Valeria Mondelli2, Sentil Kumaran Satyanarayanan3, Yi-Ju Chiang4, Hui-Ting Chen4, Kuan-Pin Su5, Carmine M Pariante2.   

Abstract

BACKGROUND: Hypothalamus-Pituitary-Adrenal (HPA) axis dysregulation, inflammation and imbalance of neurotrophins have been suggested in attention deficit hyperactivity disorder (ADHD), but the results have not been conclusive. The aim of this study is to investigate the levels of salivary cortisol across 4-time points during the day, and of morning plasma inflammatory biomarkers and neurotrophins, in youth with ADHD and in typically developing youth (TD), with stratification by age, ADHD subtypes and oppositional defiant disorder (ODD) comorbidity in Taiwan.
METHODS: We conducted a case-control study measuring saliva cortisol levels at 4 different time points during the day (at awakening, noon, 1800 h and bedtime) and morning plasma levels of inflammatory and neurotrophins biomarkers in youth with ADHD (n = 98, age 6-18 years old with mean age 9.32 ± 3.05 years) and TD (n = 21, age 6-18 years old with mean age 9.19 ± 2.96 years) in Taiwan.
RESULTS: Our study showed that youth with ADHD had lower levels of bedtime salivary cortisol (effects size (ES) = -0.04, p = .023), with children with the combined form of the disorder (with inattention, hyperactivity and impulsivity all present) having the lowest awakening salivary cortisol levels. ADHD youth also had higher levels of plasma high-sensitivity C-reactive protein (hs-CRP) and interleukin (IL)-6 (ES = 0.85-1.20, p < .0001), and lower plasma tumor necrosis factor-alpha (ES = -0.69, p = .009) and brain-derived neurotrophic factors (BDNF) (ES = -1.13, p < .0001). Both ADHD groups regardless of ODD comorbidity had higher levels of IL-6 (p < .0001) and lower levels BDNF (p < .0001).
CONCLUSION: The lower bedtime salivary cortisol levels and higher levels of inflammatory biomarkers in youth with ADHD further support the role of abnormal HPA axis and inflammation in ADHD. Moreover, the lower levels of BDNF in ADHD also indicate that BDNF may be a potential biomarker in this disorder that is part of a broader biological dysfunction.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Attention deficit hyperactivity disorder; Cortisol; HPA axis; Inflammation; Neurotrophins; Youth

Mesh:

Substances:

Year:  2020        PMID: 32418647     DOI: 10.1016/j.bbi.2020.05.017

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  12 in total

1.  Cord serum brain-derived neurotrophic factor levels at birth associate with temperament outcomes at one year.

Authors:  Hayley Dingsdale; Samantha M Garay; Hannah R Tyson; Katrina A Savory; Lorna A Sumption; Jemima S Kelleher; Kate Langley; Stephanie Van Goozen; Rosalind M John
Journal:  J Psychiatr Res       Date:  2022-03-12       Impact factor: 5.250

2.  The role of glucocorticoid receptor gene in the association between attention deficit-hyperactivity disorder and smaller brain structures.

Authors:  Claiton H D Bau; Diego L Rovaris; Cibele E Bandeira; Eugenio H Grevet; Renata B Cupertino; Maria E de Araujo Tavares; Clara S Gusmão; Djenifer B Kappel; Eduardo S Vitola; Felipe A Picon; Luís A Rohde; Bruna S da Silva
Journal:  J Neural Transm (Vienna)       Date:  2021-10-05       Impact factor: 3.575

3.  Increased Alopecia Areata Risk in Children with Attention-Deficit/Hyperactivity Disorder and the Impact of Methylphenidate Use: A Nationwide Population-Based Cohort Study.

Authors:  Hsing-Ying Ho; Chih-Kai Wong; Szu-Yuan Wu; Ray C Hsiao; Yi-Lung Chen; Cheng-Fang Yen
Journal:  Int J Environ Res Public Health       Date:  2021-02-01       Impact factor: 3.390

4.  A Different View on the Etiopathogenesis of Attention-deficit Hyperactivity Disorder from an Inflammation Perspective.

Authors:  Semiha Dursun; Esra Demirci; Eser Kilic; Sevgi Ozmen
Journal:  Clin Psychopharmacol Neurosci       Date:  2021-02-28       Impact factor: 2.582

5.  Gut microbiota and plasma cytokine levels in patients with attention-deficit/hyperactivity disorder.

Authors:  Liang-Jen Wang; Sung-Chou Li; Shiao-Wen Li; Ho-Chang Kuo; Sheng-Yu Lee; Lien-Hung Huang; Chia-Yin Chin; Chia-Yu Yang
Journal:  Transl Psychiatry       Date:  2022-02-23       Impact factor: 6.222

6.  Effect of Atomoxetine on Behavioral Difficulties and Growth Development of Primary School Children with Attention-Deficit/Hyperactivity Disorder: A Prospective Study.

Authors:  Huiya Mei; Ruijin Xie; Tianxiao Li; Zongxin Chen; Yueying Liu; Chenyu Sun
Journal:  Children (Basel)       Date:  2022-02-06

7.  Genetic estimates of correlation and causality between blood-based biomarkers and psychiatric disorders.

Authors:  William R Reay; Dylan J Kiltschewskij; Michael P Geaghan; Joshua R Atkins; Vaughan J Carr; Melissa J Green; Murray J Cairns
Journal:  Sci Adv       Date:  2022-04-06       Impact factor: 14.136

8.  Temperament Dimensions and Awakening Cortisol Levels in Attention-Deficit/Hyperactivity Disorder.

Authors:  Alessandra Carta; Isabella Vainieri; Anna-Sophie Rommel; Alessandro Zuddas; Jonna Kuntsi; Stefano Sotgiu; Nicoletta Adamo
Journal:  Front Psychiatry       Date:  2022-04-25       Impact factor: 5.435

9.  The association between heightened ADHD symptoms and cytokine and fatty acid concentrations during pregnancy.

Authors:  Hanna C Gustafsson; Geoffrey A Dunn; A J Mitchell; Kathleen F Holton; Jennifer M Loftis; Joel T Nigg; Elinor L Sullivan
Journal:  Front Psychiatry       Date:  2022-07-22       Impact factor: 5.435

10.  Cytokine Levels and Neuropsychological Function among Patients with Attention-Deficit/Hyperactivity Disorder and Atopic Diseases.

Authors:  Shung-Jie Chang; Ho-Chang Kuo; Wen-Jiun Chou; Ching-Shu Tsai; Sheng-Yu Lee; Liang-Jen Wang
Journal:  J Pers Med       Date:  2022-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.